Patent · US Active

Hybrid biodegradable/non-biodegradable stent, delivery system and method of treating a vascular condition

US9056157B2 · kind B2 · utility

8Cited by
14References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 7, 2006
Grant dateJun 16, 2015
Priority date
Expiry dateOct 25, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/00
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An intraluminal stent, an intraluminal stent delivery system, and a method of treating a vascular condition. The stent includes a framework composed of a biodegradable material. At least one strut is composed of a non-biodegradable material. The framework is operably attached to the at least one strut. The delivery system includes a catheter and a stent disposed on a portion of the catheter. The stent includes a framework composed of a biodegradable material. The stent further includes at least one strut composed of a non-biodegradable material. The framework is operably attached to the at least one strut. The method includes positioning an intraluminal stent via a catheter within a vessel. The stent includes at least one strut that is composed of a non-biodegradable material and is operably attached to a framework. The framework expands during deployment of the intraluminal stent. The framework is allowed to biodegrade within the vessel.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.